MBX Biosciences (MBX) said late Monday it has closed its upsized initial public offering of more than 11.7 million shares at $16 apiece for gross proceeds of about $187.7 million.
The closed offering includes 1.53 million shares issued upon the exercise in full by the underwriters of their option to buy more shares, the company said.
The shares started trading on Nasdaq on Friday, the company added.
Shares of the company rose 1.6% in recent after-hours activity.
Price: 22.00, Change: +0.35, Percent Change: +1.62
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.